May Hill Capital
PFE icon

May Hill Capital’s Pfizer PFE Stock Holding History

May Hill Capital’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$416K Buy
14,575
+5,232
+56% +$139K 0.08% 150
2026
Q2 		$225K Sell
9,343
-2,842
-23% -$74.3K 0.05% 228
2026
Q1 		$342K Buy
12,185
+2,997
+33% +$79.8K 0.09% 162
2025
Q4 		$229K Sell
9,188
-23
-0.2% -$580 0.06% 179
2025
Q3 		$235K Buy
+9,211
New +$227K 0.07% 170

Other funds holding PFE

Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 26.62% 1-Year Est. Return

May Hill Capital's PFE Position: Q3 2026 in Review

May Hill Capital increased its Pfizer (PFE) stake by 56% in Q3 2026, buying an estimated $139K and bringing the position to 14,575 shares worth $416K. The position accounts for 0.08% of the portfolio, ranked #150.

May Hill Capital first reported a position in PFE in Q3 2025 and has held it in 5 quarters since. 1,647 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • May Hill Capital held 14,575 shares of Pfizer worth $416K as of Q3 2026.
  • May Hill Capital bought 5,232 Pfizer shares in Q3 2026, an estimated $139K.
  • Pfizer made up 0.08% of May Hill Capital's portfolio in Q3 2026, its #150 holding.
  • May Hill Capital first reported a position in Pfizer in Q3 2025 and has held it in 5 quarters since.
  • 1,647 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on May Hill Capital's 13F filing for Q3 2026, filed 3 Nov 2026.